Immune Response to the Consumption of Lactobacillus GG and FOS in Patients With Recurrent Herpes Labialis
NCT ID: NCT03307772
Last Updated: 2017-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
78 participants
INTERVENTIONAL
2008-12-15
2009-10-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Prebiotics and probiotics have both been shown to have a favorable and supportive effect on the immune system in different health conditions such as influenza, atopic dermatitis and diarrhea. So far no study has addressed the effect of the consumption of pre- and/or probiotics in a population with recurrent herpes labialis.
Aim of the study: The present study investigated the effect of pre- or probiotics or a combination of the two on the recurrence of herpes labialis lesions as well as on the immune system in general.
Design: 78 Patients were eligible to participate in the study and after a run-in period of two weeks consuming a placebo minidrink were randomized to one of the four experimental groups, these were: placebo minidrink (n=), prebiotic (fructooligosaccharides) minidrink (n=), probiotic (Lactobacillus rhamnosus GG or LGG) minidrink (n=) or a minidrink containing a combination of a pre- and probiotic. These minidrinks were consumed for another 5 weeks. At day 33 of the study the lip most prone to the development of a lesion was stimulated with UVB in order to provoke a lesion. During the entire study period subjects were checked for any clinical signs of a lesion, completed a self-assessment regarding the lesion and a quality of life questionnaire at baseline (day 14) and the end of the study (day 49). In addition, a blood sample was collected at baseline and at the end of the study to be analyzed for general and HSV-specific antibodies, intracellular cytokine concentrations and parameters of the innate immune response such as natural killer cell activity and phagocytosis.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo drink
The placebo drink consists of fermented low-fat milk with no added Lactobacillus GG.(placebo)
Placebo
LGG Drink (
The probiotic drink consists of fermented low-fat milk with added Lactobacillus GG. (probiotics)
Probiotics
FOS Drink
The prebiotics drink consists of fermented low-fat milk with fructooligosaccharides. (prebiotics)
Prebiotics
LGG e FOS Drink
The probiotics and prebiotics drink consists of acidified low-fat milk with added Lactobacillus GG and fructooligosaccharides (prebiotics and probiotics)
Prebiotics and Probiotics
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Probiotics
Prebiotics
Prebiotics and Probiotics
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of recurrent herpes labialis at most 3 episodes after exposure to sunlight in the previous 12 months
* Fitzpatrick skin type 1 to 4
* No presence of herpes labialis lesion at the time of recruitment
* Consent to the study and to comply with study product
* Agreement to adhere to the prescribed list of food and nutrients as provided at the start of the study
Exclusion Criteria
* Intolerance for milk protein or lactose
* Daily consumption of probiotic products 1 month before start of the study
* Treatment with acyclovir or other medication believed to interfere with immune responses at the time of the study
* Participation in any herpes UVB reactivation study within the previous three months
* Episode of herpes labialis within 30 days before enrolment in the study
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sprim Advanced Life Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08-SBUS-2-GRA-01 A
Identifier Type: -
Identifier Source: org_study_id